Table 4 Response to therapy
From: Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
Response | N (%) |
|---|---|
Complete response | 1 (4 %) |
Partial response | 4 (15 %) |
Stable disease | 11 (41 %) |
Progressive disease | 11 (41 %) |